REFERENCES
- Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 2002;39:834–842.
- Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol. 2001;79:253–262.
- Kantarci G, Ozener C, Tokay S, Bihorac A, Akoğlu E. QT dispersion in hemodialysis and CAPD patients. Nephron. 2002;91:739–741.
- Van Biesen W, Vanholder R, Verbeke F, Lameire N. Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality? Perit Dial Int. 2006;26:429–434.
- Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int Suppl. 2006;103:3–11.
- Selby NM, Burton JO, Chesterton LJ, McIntyre CW. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol. 2006;1:1216–1225.
- Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis. 2006;47:830–841.
- McIntyre CW, Burton JO, Selby NM, . Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008;3:19–26.
- Selby NM, McIntyre CM. Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int. 2010;30:1–7.
- Selby NM, Fonseca S, Hulme L, Fluck RJ, Taal MW, McIntyre CW. Automated peritoneal dialysis has significant effects on systemic hemodynamic. Perit Dial Int. 2006;26:328–335.
- Selby NM, Fialova J, Burton JO, McIntyre CW. The hemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant. 2007;22:870–879.
- Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrology (Carlton). 2005;10:109–112.
- Yildiz A, Akkaya V, Sahin S, . QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients. Perit Dial Int. 2001;21:186–192.
- Seino Y, Ogawa A, Yamashita T, . Application of NT-proBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail. 2004;6:295–300.
- Locatelli F, Eckardt KU, Macdougall IC, . Cardiovascular Risk Reduction in Early Anaemia Trial with epoetin beta investigators and coordinators. Value of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: Results from the CREATE study. Curr Med Res Opin. 2010;26:2543–2552.
- Kim YK, Shin SJ, Ihm SH, . Longitudinal changes of left ventricular filling pressure and N-terminal pro-brain natriuretic peptide on chronic hemodialysis. Clin Nephrol. 2010;74:190–197.
- Taskapan MC, Taskapan H, Ulutas O, Orhan M, Sahin I. Relationships between brain natriuretic peptide, troponin I and QT dispersion in asymptomatic dialysis patients. Ren Fail. 2007;29:221–225.
- Paniagua R, Ventura MD, Avila-Díaz M, . NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25:551–557.
- Maksić D, Colić M, Stanković-Popović V, Radojević M, Bokonjić D. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis. Med Pregl. 2007;60(Suppl. 2):53–57.